Final guidance for pharmacy compounding of human drug products under Section 503A
Blankenship, C.E.
International Journal of Pharmaceutical Compounding 18(5): 379-380
2014
ISSN/ISBN: 1092-4221 PMID: 25577886 Document Number: 678338
Document emailed within 1 workday
Related Documents
1982: Pharmaceutical Reimbursement Board; final maximum allowable cost (MAC) determinations for certain drug products--Health Care Financing Administration. Final notice Federal Register 47(251): 58370-58372Sallengs, D. 1997: The use of computer technology in the compounding pharmacy International Journal of Pharmaceutical Compounding 1(3): 162-164
Moore, R. 2014: Using Facebook to market your compounding pharmacy International Journal of Pharmaceutical Compounding 18(6): 490-491
Niimi, S. 2015: Development of guidance for the approval process of brand-new medical products and regenerative medicine products Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 133: 1-7
Allen, L.V. 2003: Containment of hazardous particulates in the compounding pharmacy International Journal of Pharmaceutical Compounding 7(4): 281-285
Moore, R. 2012: Ways to incorporate facebook into your compounding pharmacy International Journal of Pharmaceutical Compounding 16(3): 224-225
Allen, L.V. 2013: Physicians, pharmacists, and the importance of quality pharmacy compounding International Journal of Pharmaceutical Compounding 17(6): 477-479
de Souza, H.Guedes.; Garcez, M.do.Carmo.; Pinheiro, V.A. 2009: Postscription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective International Journal of Pharmaceutical Compounding 13(1): 87-88
Smith, L.K. 2002: Regulatory and operational issues of founding a compounding pharmacy International Journal of Pharmaceutical Compounding 6(6): 434-437
Timko, R.J. 2015: Applying Quality by Design Concepts to Pharmacy Compounding International Journal of Pharmaceutical Compounding 19(6): 453-463
Gochenauer, A.E.; Holmes, E.R.; Barber, K.E.; Forsythe, L.R. 2019: The Current Landscape of Veterinary Compounding in the Pharmacy Setting International Journal of Pharmaceutical Compounding 23(5): 422-427
Lees, D.J. 2014: Pharmacy benefit managers and compounding pharmacists: billing for services International Journal of Pharmaceutical Compounding 18(1): 87
Allen, L.V.; Okeke, C.C. 2007: Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2 International Journal of Pharmaceutical Compounding 11(4): 313-323
Galbraith, W.; Shadid, J. 2012: Compounding and dispensing errors before and after implementing barcode technology in a nuclear pharmacy International Journal of Pharmaceutical Compounding 16(3): 253-256
Grilli, A.; Sutton, S. 2015: Agar transfer devices for environmental sampling in the compounding pharmacy: science and compliance International Journal of Pharmaceutical Compounding 19(1): 30-37
Mixon, B.; Ille, G. 2009: Preventing nonmicrobiologic airborne contamination in the compounding pharmacy: ensuring a safe environment for compounders, staff, and clients International Journal of Pharmaceutical Compounding 13(4): 290-294
Allen, L.V. 2017: Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing International Journal of Pharmaceutical Compounding 21(5): 388-392
Shawaqfeh, M.S.; Harrington, C. 2018: Pain: Systematic Review of Pharmacy Compounding of Pain Medication International Journal of Pharmaceutical Compounding 22(1): 19-24
Williams, L.V.A. 2010: Compounding pharmacy: a unique service for a unique population International Journal of Pharmaceutical Compounding 14(1): 19-20
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318